Core Insights - The presentation is part of the 44th Annual JPMorgan Healthcare Conference, featuring Aptar's leadership team, including CEO Stephan Tanda and CFO Vanessa Kanu [1][2] Company Overview - Aptar's Pharma business constitutes 46% of the company's operations and is primarily focused on proprietary drug delivery systems, contributing two-thirds of the company's EBITDA [3] - The company also highlights the performance of its Beauty and Closures segments, which are showing significant growth [3] Technology and Capabilities - Aptar employs various advanced technologies, including fine mist pumps, aerosol valves, precision injection molding, high-speed automated assembly, and AI-assisted quality control [4]